StageZero Life Sciences Ltd.
StageZero Life Sciences Ltd. (SZLSF) Revenue
Annual & quarterly revenue history · segment & region breakdown
SZLSF · revenue · updated Jun 15, 2026
Core revenue metrics
Trailing 12 monthsStageZero Life Sciences Ltd. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 25.12% year-over-year from $0.00B in FY2022.
Revenue trend
2022 – 2003 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2022-12-31 | $0.00B | -$0.00B | -25.12% |
| 2021-12-31 | $0.01B | +$0.00B | +22.07% |
| 2020-12-31 | $0.00B | +$0.00B | +2893.29% |
| 2019-12-31 | $0.00B | -$0.00B | -25.38% |
| 2018-12-31 | $0.00B | -$0.00B | -54.85% |
| 2017-12-31 | $0.00B | -$0.00B | -60.95% |
| 2016-12-31 | $0.00B | +$0.00B | +223.54% |
| 2015-12-31 | $0.00B | -$0.00B | -84.58% |
| 2014-12-31 | $0.00B | +$0.00B | +1602.71% |
| 2013-12-31 | $0.00B | -$0.00B | -55.93% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income StageZero Life Sciences Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
StageZero Life Sciences Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from StageZero Life Sciences Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
SZLSF revenue · 4 questionsSZLSF's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 25.12% year-over-year from $0.00B in FY2022.
▸ Source: FMP · StageZero Life Sciences Ltd. SEC filings · GAAP · StageZero Life Sciences Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026